Wuhan Huada Jinuoyin Biotechnology Co., Ltd. announced that it will receive equity in round of funding on August 11, 2022. The transaction will include participation from new investors BGI Genomics Co., Ltd. for CNY 60,000,000 for 5.4545% stake, Qingdao Huada Win-Win No. 2 Venture Capital Fund Partnership (Limited Partnership) for 1.3636% stake and Kunshan Hi-Tech Venture Capital Co., Ltd. for 2.2727% stake.

After the completion of the transaction the registered capital of the company will increase from CNY 43,565,325 to CNY 47,921,858. The transaction has been approved in the ninth meeting of the third board of directors.